Cytoreductive (tumor-debulking) surgery

Hepatocellular Carcinoma

Volumn , Issue , 2008, Pages 569-581

  Lai, Eric C H ^a   Lau, W Y ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Prince of Wales Hospital   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44649130881     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812770059_0026     Document Type: Chapter

References (50)

1. Lau WY (2000). Primary hepatocellular carcinoma. In: Blumgart LH, Fong Y (eds.), Surgery of the Liver and Biliary Tract, Vol. 2, WB Saunders, London, England, pp. 1423-50.
2. Lau WY (2000). Primary liver tumors. Semin Surg Oncol 19:135-44.
3. Lau WY (2002). Management of hepatocellular carcinoma. JR Coll Surg Edinb47:389-99.
4. Lai EC, Lau WY (2005). The continuing challenge of hepatic cancer in Asia. Surgeon 3:210-5.
5. Cormier JN, Thomas KT, Chari RS, Pinson CW (2006). Management of hepatocellular carcinoma. J Gastrointest Surg 10:761-80.
6. Lau WY (2000). Local ablative therapy for hepatocellular carcinoma. Endoscopy32:644-6.
7. Lau WY, Leung TW, Yu SC, Ho SK (2003). Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 237:171-9.
8. Lau WY (2000). Radiotherapy with emphasis on radioembolization for liver tumors. In: Blumgart LH, Fong Y (eds.), Surgery of The Liver and Biliary Tract, Vol. II, WB Saunders, London, England, pp. 1545-64.
9. Lau WY, Yu SC, Lai EC, Leung TW (2006). Transarterial chemoembolization for hepatocellular carcinoma. J Am Coll Surg 202:155-68.
10. 90Yttrium microspheres. Int J Radiat Oncol Biol Phys 40:583-92.
11. Lau WY, Leung TW, Leung KL, et al. (1994). Cytoreductive surgery for hepatocellular carcinoma. Surg Oncol 3:161-6.
12. Nagashima J, Okuda K, Tanaka M, et al. (1999). Prognostic benefit in cytoreductive surgery for curatively unresectable hepatocellular carcinoma - comparison to transcatheter arterial chemoembolization. Int J Oncol 15:1117-23.
13. Shimamura Y, Gunven P, Ishii M, et al. (1993). Debulking surgery and arterial embolization for unresectable liver cancer. Hepatogastroenterology 40:10-3.
14. Yamamoto M, Iizuka H, Matsuda M, et al. (1993). The indications for tumor mass reduction surgery and subsequent multidisciplinary treatments in stage IV hepatocellular carcinoma. Surg Today 23:675-81.
15. Inoue K, Nakamura T, Kinoshita T, et al. (2004). Volume reduction surgery for advanced hepatocellular carcinoma. J Cancer Res Clin Oncol 130:362-6.
16. Ku Y, Iwasaki T, Tominaga M, et al. (2004). Reductive surgery plus percutaneous isolated hepatic perfusion for multiple advanced hepatocellular carcinoma. Ann Surg 239:53-60.
17. Wong RJ, DeCosse JJ (1990). Cytoreductive surgery. Surg Gynecol Obstet170:276-81.
18. McCarter MD, Fong Y (2001). Role for surgical cytoreduction in multimodality treatments for cancer. Ann Surg Oncol 8:38-43.
19. Pecorelli S, Odicino F, Favalli G (2000). Ovarial cancer: best timing and applications of debulking surgery. Ann Oncol 11(Suppl):141-4.
20. Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP (2006). Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 243:212-22.
21. Liu CL, Fan ST, Lo CM, et al. (2003). Hepatic resection for bilobar hepatocellular carcinoma: is it justified? Arch Surg 138:100-4.
22. Wakabayashi H, Ushiyama T, Ishimura K, et al. (2003). Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions. JSurg Oncol 82:98-103.
23. Izumi R, Shimizu K, Miyazaki I (1996). Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma. Hepatogastroenterology43:1415-20.
24. Li JQ, Zhang YQ, Zhang WZ, et al. (1995). Randomized study of chemoem-bolization as an adjuvant therapy for primary liver carcinoma after hepatectomy. J Cancer Res Clin Oncol 121:364-6.
25. Taniai N, Yoshida H, Mamada Y, et al. (2006). Is intraoperative adjuvant therapy effective for satellite lesions in patients undergoing reduction surgery for advanced hepatocellular carcinoma? Hepatogastroenterology 53:258-61.
26. Chen MS, Li JQ, Zheng Y, et al. (2006). A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321-8.
27. Sutherland LM, Williams JA, Padbury RT, et al. (2006). Radiofrequency ablation of liver tumors: a systematic review. Arch Surg 141:181-90.
28. Chen MH, Yang W, Yan K, et al. (2004). Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients - mathematic model, overlapping mode, and electrode placement process. Radiology 232:260-71.
29. Chen MH, Wei Y, Yan K, et al. (2006). Treatment strategy to optimize radiofrequency ablation for liver malignancies. JVasc Interv Radiol 17:671-83.
30. Chen MH, Yan K, Yang W, et al. (2005). Long term (5 years) outcome of radiofrequency ablation for hepatocellular carcinoma in 256 cases. Beijing Da XueXueBao 37:671-2.
31. Giorgio A, Tarantino L, de Stefano G, et al. (2003). Percutaneous sonograph-ically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma. AJRAm J Roentgenol 181:479-84.
32. Ritz JP, Lehmann KS, Isbert C, et al. (2006). In-vivo evaluation of a novel bipolar radiofrequency device for interstitial thermotherapy of liver tumors during normal and interrupted hepatic perfusion. J Surg Res 133:176-84.
33. Yamasaki T, Kurokawa F, Shirahashi H, et al. (2002). Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy. Cancer 95:2353-60.
34. Yamakado K, Nakatsuka A, Akeboshi M, et al. (2004). Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: short-term recurrences and survival. Oncol Rep 11:105-9.
35. Veltri A, Moretto P, Doriguzzi A, et al. (2006). Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol16:661-9.
36. Lam CM, Lo CM, Yuen WK, et al. (1998). Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg 85:1198-200.
37. Aramaki M, Kawano K, Sasaki A, et al. (2002). Prolonged survival after repeat resection of pulmonary metastasis from hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 9:386-8.
38. Gwak GY, Jung JO, Sung SW, Lee HS (2004). Long-term survival after pulmonary metastatectomy of hepatocellular carcinoma; treatment outcome or natural history? Hepatogastroenterology 51:1428-33.
39. Chen YJ, Hsu HS, Hsieh CC, et al. (2004). Pulmonary metastasectomy for hepatocellular carcinoma. J Chin Med Assoc 67:621-4.
40. Nakajima J, Tanaka M, Matsumoto J, et al. (2005). Appraisal of surgical treatment for pulmonary metastasis from hepatocellular carcinoma. World J Surg29:715-8.
41. Nakagawa T, Kamiyama T, Nakanishi K, et al. (2006). Pulmonary resection for metastases from hepatocellular carcinoma: factors influencing prognosis. J Thorac Cardiovasc Surg 131:1248-54.
42. Tomimaru Y, Sasaki Y, Yamada T, et al. (2006). The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma. Am J Surg 192:46-51.
43. Shuto T, Hirohashi K, Kubo S, et al. (2001). Treatment of adrenal metastases after hepatic resection of a hepatocellular carcinoma. Dig Surg 18:294-7.
44. Lo CM, Lai EC, Fan ST, et al. (1994). Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg 81:1019-21.
45. Nakayama H, Takayama T, Makuuchi M, et al. (1999). Resection of peritoneal metastases from hepatocellular carcinoma. Hepatogastroenterology 46:1049-52.
46. Poon RT, Fan ST, O’Suilleabhain CB, Wong J (2002). Aggressive management ofpatients with extrahepatic and intrahepatic recurrences ofhepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg195:311-8.
47. Yeh CN, Chen MF (2004). Resection of peritoneal implantation of hepatocellular carcinoma after hepatic resection: risk factors and prognostic analysis. World J Surg 28:382-6.
48. Yamamoto K, Takenaka K, Kawahara N, et al. (1997). Indications for palliative reduction surgery in advanced hepatocellular carcinoma. The use of a remnant tumor index. Arch Surg 132:120-3.
49. Asahara T, Itamoto T, Katayama K, et al. (1998). Indications for palliative reduction surgery for hepatocellular carcinoma with multiple intrahepatic metastases. Hiroshima JMed Sci 47:115-20.
50. Gotohda N, Kinoshita T, Konishi M, et al. (2006). New indication for reduction surgery in patients with advanced hepatocellular carcinoma with major vascular involvement. World J Surg 30:431-8.